Metformin Increases Overall Survival In Patients With Diabetes Undergoing Surgery For Colorectal Cancer
Tina Fransgaard, Lau Caspar Thygesen, Ismail Gögenur
Published 2015 · Medicine
Download PDFAnalyze on Scholarcy
AbstractBackground Emerging evidence suggests that metformin decreases the risk of developing colorectal cancer in patients with diabetes, but only few studies have examined potential survival benefits after surgery for colorectal cancer (CRC). The purpose of the study was to examine the association between diabetes and overall survival after resection for CRC. Furthermore, the association between antidiabetic medication and overall survival was examined.MethodsPatients diagnosed with CRC between January 1, 2003 and December 31, 2012 were identified through the Danish Colorectal Cancer Group’s National Clinical Database (DCCG). The Danish National Patient Register (NPR) records all hospital contacts in Denmark, and the diagnosis of diabetes was identified by combining NPR data with use of antidiabetic drugs identified through the Danish National Prescription Registry and DCCG. The Kaplan–Meier estimator and the Cox regression model adjusted for important clinical risk factors were used.ResultsA total of 30,493 patients were included in the study, of which 3391 were diagnosed with diabetes and 1962 were treated with metformin. The adjusted HR of all-cause mortality for the diabetes group was 1.12 (1.06–1.18, p < 0.0001) compared with the nondiabetes group. The adjusted HR was 0.85 (0.73–0.93, p = 0.03) for the metformin-treated group compared with the insulin-treated group.ConclusionsA 12 % increase in all-cause mortality among patients with CRC and diabetes was found. Treatment with metformin was associated with a 15 % decreased all-cause mortality compared with patients with insulin-treated diabetes.
This paper references
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Jeffrey A. Meyerhardt (2003)
Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies
Konstantinos K Tsilidis (2015)
Colorectal Cancer Outcomes, Recurrence, and Complications in Persons With and Without Diabetes Mellitus: A Systematic Review and Meta-Analysis
Kelly B. Stein (2009)
Attorneys as advocates: organizations step up to help patients navigate the legal and financial issues that often accompany a cancer diagnosis.
Carrie Printz (2015)
Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
Amikar Sehdev (2015)
The Danish National Prescription Registry
Helle Wallach Kildemoes (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea Decensi (2010)
Multimorbidity and survival in older persons with colorectal cancer.
Cary P Gross (2006)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes
Zhi-Jiang Zhang (2011)
Metformin and reduced risk of cancer in diabetic patients
Josie M. M. Evans (2005)
Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
Susanna C. Larsson (2005)
Metformin in cancer prevention and therapy.
Jacek Kasznicki (2014)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
Lisa C. Richardson (2005)
Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.
Bethany B. Barone (2008)
The Danish National Patient Register
Elsebeth Lynge (2011)
The Danish Civil Registration System. A cohort of eight million persons.
Carsten Bøcker Pedersen (2006)
Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies
Ying Jiang (2011)
Metformin: Multi-faceted protection against cancer
Sònia del Barco (2011)
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
Fernando Ovalle (2010)
Metformin: multifaceted protection against cancer. Oncotarget
S DelBarco (2011)
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
Jin Ha Lee (2012)
Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
Chris R. Garrett (2012)
Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Zubing Mei (2014)
Antidiabetic Medications and the Risk of Colorectal Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-analysis
Siddharth Singh (2013)
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Jan P. Vandenbroucke (2007)
This paper is referenced by
Metformin-induced anticancer activities: recent insights
Stephen Safe (2018)
Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients
Brianna Croft (2018)
Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies
Lili Du (2017)
Postdiagnostic Metformin Use and Survival of Patients With Colorectal Cancer: A Nationwide Cohort study.
Wen-Kuan Huang (2020)
Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
Junichi Kato (2019)
Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis
Jingtao Li (2017)
Obesity, Diabetes and Gastrointestinal Malignancy: The role of Metformin and other Anti-diabetic Therapy
Michael Ashamalla (2018)
Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study
Linda Kaerlev (2018)
Positive effect of metformin treatment in colorectal cancer patients with type 2 diabetes: national cohort study
Audrius Dulskas (2019)
Comment on: Need for Differentiating Diabetes-Specific Mortality from Total Mortality when Comparing Metformin with Insulin Regarding Cancer Survival
Tina Fransgaard (2017)
Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients
Jung Won Park (2017)
Metformina: stary lek w nowej aplikacji
Anna Dmoszyńska (2016)
Komplex jellegek genetikai hátterének elemzése
Zsolt Rónai (2018)
14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma
Jing Ding (2018)
Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences
Yunzi Wang (2020)
Metformin: An anti-diabetic drug to fight cancer.
Marie Daugan (2016)
Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register‐based study
Tina Fransgaard (2018)
Erratum to: The need for differentiating diabetes-specific mortality from total mortality when comparing metformin with insulin regarding cancer survival
Min Wei (2016)
Obesity and diabetes as prognostic factors in patients with colorectal cancer.
Ioannis A. Voutsadakis (2017)
Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
Fanqiang Meng (2017)
PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis
Norihiro Yamaguchi (2019)
Outcomes of cancer surgery after inhalational and intravenous anesthesia: A systematic review.
Sinor Soltanizadeh (2017)
The need for differentiating diabetes-specific mortality from total mortality when comparing metformin with insulin regarding cancer survival
Min Wei (2016)
Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
Muhamad N.A. Kamarudin (2019)
Metformin and Colorectal Cancer - A Systematic Review.
Jarek Kobiela (2018)
A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus
Marie C Bradley (2018)
The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
Shan Tian (2017)
Metformin and blood cancers
Ademar Dantas da Cunha Júnior (2018)
Impact of long-term antihypertensive and antidiabetic medications on the prognosis of post-surgical colorectal cancer: the Fujian prospective investigation of cancer (FIESTA) study
Feng Peng (2018)
Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
Cheng-Ann Winston Ng (2020)
The Potential Effect of Metformin on Cancer: An Umbrella Review
Hong Yu (2019)
Type 2 diabetes mellitus and cancer: carcinogenesis and protective effect of antidiabetic drugs
Gabriel Ataíde Monção Higor Rabelo Guedes Hadison Santos Nogueira Curzio (2017)See more